In vitro dose effect relationships of actinium-225- and lutetium-177-labeled PSMA-I&T.
Eline A M RuigrokGiulia TamborinoErik de BloisStefan J RoobolNicole VerkaikMarijke De Saint-HubertMark W KonijnenbergWytske M van WeerdenMarion de JongJulie NonnekensPublished in: European journal of nuclear medicine and molecular imaging (2022)
Lu]Lu-PSMA-I&T underlines the therapeutic potential for the treatment of PCa.